WASHINGTON (AP) - Some low-cost generic drugs that have helped restrain health care costs for decades are seeing unexpected price spikes of up to 8,000 percent, prompting a backlash from patients, ...
Despite their "conceptual parallels," biosimilars are in no way, shape or form to be confused with generics. That's the message the Australian Therapeutics Goods Administration (TGA) sent out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results